Syntenin inhibition impairs stroma-tumor communication in Multiple Myeloma and improves Bortezomib treatment efficiency

ABSTRACT: In multiple myeloma, the objective is to assess the impact of syntenin knockout on the secretory profile of bone marrow stromal cells using the HS-5 model.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Cell

DISEASE(S): Multiple Myeloma

SUBMITTER: AUDEBERT Stephane  

LAB HEAD: Audebert Stéphane, PhD

PROVIDER: PXD064458 | Pride | 2025-07-26

REPOSITORIES: Pride